David Young

Insider Reports History

Location
Columbia, MD
Signature
/s/ David Young by John J. Wolfel, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Sponsored

Holdings reported by David Young:

Company Role Class Num Shares Value Price $ Report Date Ownership
Processa Pharmaceuticals, Inc. Pres. Research & Development, Director Restricted Stock Units 0 $43,015 $1.71 01 Jan 2026 Direct
Processa Pharmaceuticals, Inc. Pres. Research & Development, Director Common Stock 10,562 $26,774 $2.54 31 Mar 2026 Direct
Processa Pharmaceuticals, Inc. Pres. Research & Development, Director Common Stock 1,242 $3,576 $2.88 31 Mar 2026 By Young-Plaisance Revocable Trust
Processa Pharmaceuticals, Inc. Pres. Research & Development, Director Common Stock 742 $2,136 $2.88 31 Mar 2026 By CorLyst, LLC
Processa Pharmaceuticals, Inc. Pres. Research & Development, Director Common Stock 432 $1,244 $2.88 31 Mar 2026 By Family Entities
Processa Pharmaceuticals, Inc. Pres. Research & Development, Director Stock Options (Right to Buy) 333,000 01 Oct 2025 Direct
Processa Pharmaceuticals, Inc. Pres. Research & Development, Director Warrants 62,250 29 Jan 2025 Direct

Insider Reports Filed by David Young

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PCSA Processa Pharmaceuticals, Inc. 31 Mar 2026 1 +$4,588 4 Pres. Research & Development, Director 01 Apr 2026, 17:20
PCSA Processa Pharmaceuticals, Inc. 01 Jan 2026 2 $0 4 Pres. Research & Development, Director 04 Feb 2026, 17:09
PCSA Processa Pharmaceuticals, Inc. 01 Oct 2025 2 $0 4 Pres. Research & Development, Director 03 Oct 2025, 16:25
PCSA Processa Pharmaceuticals, Inc. 24 Jul 2025 0 $0 4/A Pres. Research & Development, Director 18 Sep 2025, 16:24
PCSA Processa Pharmaceuticals, Inc. 01 Apr 2025 2 -$2,202 4 Pres. Research & Development, Director 11 Apr 2025, 17:16
PCSA Processa Pharmaceuticals, Inc. 27 Jan 2025 2 $0 4/A Pres. Research & Development, Director 18 Feb 2025, 17:57
PCSA Processa Pharmaceuticals, Inc. 05 Apr 2024 8 -$1,927 4 Pres. Research & Development, Director 02 Aug 2024, 17:09
PCSA Processa Pharmaceuticals, Inc. 07 Feb 2024 1 +$51,526 4 Pres. Research & Development, Director 08 Feb 2024, 16:30
PCSA Processa Pharmaceuticals, Inc. 06 Feb 2024 1 +$50,504 4 Pres. Research & Development, Director 07 Feb 2024, 16:22
PCSA Processa Pharmaceuticals, Inc. 01 Jan 2024 3 -$1,445 4 Pres. Research & Development, Director 12 Apr 2024, 17:01
PCSA Processa Pharmaceuticals, Inc. 12 Oct 2023 1 +$45,030 4 Pres. Research & Development, Director, 10%+ Owner 12 Oct 2023, 17:54
PCSA Processa Pharmaceuticals, Inc. 10 Oct 2023 1 +$34,080 4 Pres. Research & Development, Director, 10%+ Owner 10 Oct 2023, 17:03
PCSA Processa Pharmaceuticals, Inc. 12 Jun 2023 1 +$32,000 4 President & CEO, Director, 10%+ Owner 12 Jun 2023, 16:31
PCSA Processa Pharmaceuticals, Inc. 14 Apr 2023 1 +$10,998 4 President & CEO, Director, 10%+ Owner 14 Apr 2023, 18:16
PCSA Processa Pharmaceuticals, Inc. 11 Apr 2023 3 +$29,000 4 President & CEO, Director, 10%+ Owner 13 Apr 2023, 16:51
PCSA Processa Pharmaceuticals, Inc. 09 Feb 2023 1 +$15,000 4 President & CEO, Director, 10%+ Owner 10 Feb 2023, 16:04
PCSA Processa Pharmaceuticals, Inc. 31 Dec 2022 2 $0 4 President & CEO, Director, 10%+ Owner 04 Jan 2023, 16:39
PCSA Processa Pharmaceuticals, Inc. 30 Sep 2022 1 $0 4 President & CEO, Director, 10%+ Owner 03 Oct 2022, 16:48
PCSA Processa Pharmaceuticals, Inc. 16 Aug 2022 1 $0 4 President & CEO, Director, 10%+ Owner 23 Aug 2022, 16:30
PCSA Processa Pharmaceuticals, Inc. 05 Aug 2022 2 -$8,023 4 President & CEO, Director, 10%+ Owner 09 Aug 2022, 16:26
PCSA Processa Pharmaceuticals, Inc. 30 Jun 2022 1 $0 4 Chief Executive Officer, Director, 10%+ Owner 05 Jul 2022, 17:33
PCSA Processa Pharmaceuticals, Inc. 01 Apr 2022 1 $0 4 Chief Executive Officer, Director, 10%+ Owner 11 Apr 2022, 18:00
PCSA Processa Pharmaceuticals, Inc. 31 Dec 2021 1 $0 4/A Chief Executive Officer, Director, 10%+ Owner 06 Jan 2022, 16:31
PCSA Processa Pharmaceuticals, Inc. 01 Nov 2021 2 $0 4 Chief Executive Officer, Director, 10%+ Owner 04 Apr 2022, 17:45
PCSA Processa Pharmaceuticals, Inc. 30 Sep 2021 1 $0 4/A Chief Executive Officer, Director, 10%+ Owner 06 Jan 2022, 14:57
PCSA Processa Pharmaceuticals, Inc. 05 Aug 2021 1 $0 4 Chief Executive Officer, Director, 10%+ Owner 09 Aug 2021, 16:33
PCSA Processa Pharmaceuticals, Inc. 08 Jul 2021 3 $0 4 Chief Executive Officer, Director, 10%+ Owner 09 Jul 2021, 16:33
PCSA Processa Pharmaceuticals, Inc. 23 Jun 2021 1 +$76,716 4 Chief Executive Officer, Director, 10%+ Owner 23 Jun 2021, 17:12
PCSA Processa Pharmaceuticals, Inc. 08 Jun 2021 1 $0 4 Chief Executive Officer, Director, 10%+ Owner 10 Jun 2021, 17:04

Sponsored